Riskpilot← Back to searchSign inGet full accessMediRoyal Nordic AB
ABActiveOrg 5566307970Staffans Väg 6 BWholesale of pharmaceutical and medical goods · NACE 4646Est. 200213 employees
Revenue 2024
SEK 60,4M
+5% vs 2023
EBITDA margin
6.5%
-29% vs 2023
Equity ratio
66.2%
Financial strength
Net profit 2024
SEK 3,1M
-29% vs 2023
| Revenue | SEK 60,4M | +5% |
| EBITDA | SEK 4M | -29% |
| Net profit | SEK 3,1M | -29% |
| Total assets | SEK 23,5M | +8% |
| Equity | SEK 15,6M | +7% |
| Employees | 13 | — |
Legal name
MediRoyal Nordic AB
Org number
5566307970
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31 augusti 2002
Share capital
SEK 500 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva försäljning och marknadsföring av ortopediska produkter och rehabiliteringsprodukter samt därmed idka förenlig verksamhet.
Address
Staffans Väg 6 B
Phone
+46850676600
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 45 103 | 48 483 | 49 730 | 57 571 | 60 444 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 951 | 1 557 | 959 | 5 574 | 3 954 |
| Depreciation & amort. | −71 | −49 | −69 | −145 | −163 |
| EBIT | 880 | 1 508 | 890 | 5 429 | 3 791 |
| Net financials | −9 | −35 | −32 | 50 | 129 |
| Profit before tax | 871 | 1 473 | 858 | 5 478 | 3 919 |
| Tax | −60 | −314 | −182 | −1 135 | −846 |
| Net profit | 811 | 1 159 | 676 | 4 343 | 3 073 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 076 | 16 638 | 17 523 | 21 792 | 23 502 |
| Equity | 8 754 | 9 913 | 10 139 | 14 482 | 15 555 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 322 | 6 725 | 7 384 | 7 310 | 7 946 |
| Total debt | 7 322 | 6 725 | 7 384 | 7 310 | 7 946 |
EBITDA margin
6.5%
This company
15.8%
Market median
-59% vs market
20202024
Equity ratio
66.2%
This company
38.2%
Market median
+73% vs market
20202024
Return on equity
19.8%
This company
18.4%
Market median
+8% vs market
20202024
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20202024
Asset turnover
2.57×
This company
1.12×
Market median
+129% vs market
20202024
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LT Chief Executive Officer | Chief Executive Officer | 2021 |
BM Chief Auditor | Chief Auditor | 2022 |
| Former (3) | ||
PJ Audit | Audit | 2020 – 2020 |
KK Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Audit | 2020 – 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MediRoyal Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Jansson | Audit | 0 companies |
| Lars Thomas Eriksson | Chief Executive Officer | 0 companies |
| Karin Kristina Margareta Benitez | Chief Executive Officer | 0 companies |
| Johan Patrik Kristian Lyckestedt | Audit | 0 companies |
| Bengt Magnus Wallenius | Chief Auditor | 0 companies |
| Bo-Jui Lin | Board of Directors | 0 companies |
| Ming-Wei Lin | Board of Directors | 0 companies |
| Lars Göran Eriksson | Chairman | 0 companies |